文献速递糖尿病

1型糖尿病在DCCT/EDIC研究30年随访中的严重低血糖风险

Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study.
PubMed 文献 · Diabetes Care · 2017-05-26

在DCCT/EDIC队列约30年随访中,一半受试者报告过严重低血糖。EDIC期间,原强化治疗组严重低血糖发生率下降,原常规治疗组上升,两组发生率趋于接近(每100患者年36.6 vs 40.8,相对风险1.12,95%CI 0.91-1.37)。既往严重低血糖发作是后续发作的最强预测因素。

要点

  • DCCT/EDIC队列中约半数受试者报告过严重低血糖事件。
  • EDIC期间原强化组严重低血糖率下降,原常规组上升,两组趋于接近。
  • 既往严重低血糖发作是后续发作的最强预测因素。

核心结论

  • 随着糖尿病病程延长和HbA1c水平相近,DCCT/EDIC两个治疗组的严重低血糖发生率随时间趋于平衡。
  • 严重低血糖持续存在,仍是1型糖尿病患者全生命周期的挑战。

研究设计与样本

  • DCCT/EDIC队列随访研究,DCCT期间每季度报告严重低血糖,EDIC期间每年报告(患者回忆前3个月发作)。
  • 分析了随时间影响严重低血糖发生率的危险因素。

主要发现

  • DCCT/EDIC队列中一半受试者报告过严重低血糖发作。
  • EDIC期间,原DCCT强化治疗组严重低血糖发生率下降,原常规治疗组上升,两组发生率相近(每100患者年36.6 vs 40.8),相对风险1.12(95%CI 0.91-1.37)。
  • 既往严重低血糖发作是后续发作的最强预测因素。
  • 以青少年期进入DCCT研究与严重低血糖风险增加相关,而使用胰岛素泵与较低风险相关。
  • 两个治疗组中,严重低血糖发生率均随HbA1c降低而升高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: During the Diabetes Control and Complications Trial (DCCT), intensive diabetes therapy achieving a mean HbA1c of ∼7% was associated with a threefold increase in the rate of severe hypoglycemia (defined as requiring assistance) compared with conventional diabetes therapy with a mean HbA1c of 9% (61.2 vs. 18.7 per 100 patient-years). After ∼30 years of follow-up, we investigated the rates of severe hypoglycemia in the DCCT/Epidemiology of Diabetes Inverventions and Complications (EDIC) cohort. RESEARCH DESIGN AND METHODS: Rates of severe hypoglycemia were reported quarterly during DCCT and annually during EDIC (i.e., patient recall of episodes in the preceding 3 months). Risk factors influencing the rate of severe hypoglycemia over time were investigated. RESULTS: One-half of the DCCT/EDIC cohort reported episodes of severe hypoglycemia. During EDIC, rates of severe hypoglycemia fell in the former DCCT intensive treatment group but rose in the former conventional treatment group, resulting in similar rates (36.6 vs. 40.8 episodes per 100 patient-years, respectively) with a relative risk of 1.12 (95% CI 0.91-1.37). A preceding episode of severe hypoglycemia was the most powerful predictor of subsequent episodes. Entry into the DCCT study as an adolescent was associated with an increased risk of severe hypoglycemia, whereas insulin pump use was associated with a lower risk. Severe hypoglycemia rates increased with lower HbA1c similarly among participants in both treatment groups. CONCLUSIONS: Rates of severe hypoglycemia have equilibrated over time between the two DCCT/EDIC treatment groups in association with advancing duration of diabetes and similar HbA1c levels. Severe hypoglycemia persists and remains a challenge for patients with type 1 diabetes across their life span.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Gubitosi-Klug RA, Braffett BH, White NH, et al. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care. 2017. PMID: 28550194. doi:10.2337/dc16-2723

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。